Key Drivers
- Profitability Rebound
- Stronger Cash Flow
- Heavy Leverage
AIAI Summary
ACHC has shifted from a turnaround to a “prove-it” story: the latest quarter showed real operating leverage and strong free cash flow, but with litigation/regulatory scrutiny and meaningful debt still hanging over the name, investors should only lean in if management can sustain margin gains and facility ramp execution through the next few quarters.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profitability Rebound
- •Stronger Cash Flow
- •Heavy Leverage
ACHC showed a sharp quarterly turnaround in profitability and cash flow by mid-2026, but heavy leverage, modest liquidity, and a deeply loss-making 2025 full year still keep the overall risk profile elevated.
Price Behavior
Key Price Behavior Insights:
- •Downtrend pressure
- •Base holding
- •Lower-high pattern
ACHC has weakened over the last month but is still holding a low-30s recovery base, with support near $30 and resistance around $32 as momentum remains fragile.
Rebounded from $27.35 in late
Sentiment & News
Key News Insights:
- •Earnings Beat
- •Legal Scrutiny
- •Valuation Pressure
Acadia Healthcare beat Q2 estimates and raised guidance on stronger admissions and residential growth, but ongoing legal scrutiny, valuation concerns, and recent share weakness keep sentiment mixed.
The earnings beat and raised guidance support the outlook, but litigation and valuation pressure are likely to keep ACHC volatile
Similar Companies in Healthcare
Other companies in the same sector with AI ratings